Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Alexandria Forbes | M | 59 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | 9 years |
Michael Stuart Naylor | M | 61 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | 9 years |
Elyssa Steiner | F | - | 7 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Stephen Herbert | M | 60 | 23 years | |
Donald Layden | M | 66 | 1 years | |
David S. Rector | M | 76 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
George Raymond Jensen | M | 75 | 19 years | |
Leslie J. Browne | M | 74 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 4 years |
Harlan Waksal | M | 71 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 8 years |
Vaughn V. Smider | M | 54 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
Ronald Martell | M | 62 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 1 years |
Jack van Hulst | M | 85 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 7 years |
Albin Moschner | M | 72 | 23 years | |
Steven Katz | M | 76 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 11 years |
Robert L. Metzger | M | 56 | 4 years | |
Phillip Frost | M | 87 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
Jeff Vogt | M | 51 | 2 years | |
Thomas C. Quick | M | 68 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
John E. Thompson | M | 82 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
Ingrid S. Stafford | F | 70 | 1 years | |
William J. Reilly | M | 76 | 8 years | |
Warren John Isabelle | M | 71 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 5 years |
Bradley Tirpak | M | 54 | 4 years | |
Deborah G. Arnold | F | 73 | 3 years | |
Steve G. Illes | M | - | - | |
Jack Edward Price | M | 78 | - | |
Glen E. Goold | M | 53 | 2 years | |
Steven D. Barnhart | M | 62 | 24 years | |
William J. Schoch | M | 59 | 8 years | |
Frank A. Petito | M | 56 | 2 years | |
Patricia A. Oelrich | F | 70 | 1 years | |
Don Brashears | M | - |
Rider University
| 12 years |
Rudolf Stalder | M | 83 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 15 years |
Michael K. Lawlor | M | 63 | 23 years | |
Leland P. Maxwell | M | 77 | - | |
Gregory S. Moss | M | 40 |
MeiraGTx Ltd.
MeiraGTx Ltd. Pharmaceuticals: MajorHealth Technology MeiraGTx Ltd. engages in the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company was founded on March 20, 1991 and is headquartered in London, the United Kingdom. | 1 years |
Denis Kouznetsov | M | - | 16 years | |
Priyanka Singh | F | 44 | 2 years | |
Sunil Sabharwal | M | 60 | - | |
Steven Rubin | M | 63 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
Richard S. Dondero | M | 74 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 10 years |
David M. DeMedio | M | 52 | 16 years | |
John N. Braca | M | 65 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
Kelly Kay | F | - | - | |
Francis Reynolds | M | 61 |
Rider University
| 4 years |
William Schwarz | M | - |
Rider University
| 4 years |
Chris M. Sowa | M | - |
Rider University
| 4 years |
Vincent Arscott | M | - |
Rider University
| 4 years |
William T. Haines | M | 58 | - | |
Matthew McConnell | M | 55 | 1 years | |
Paul R. Tomkins | M | 66 |
Rider University
| 4 years |
Jerry A. Pizza | M | - |
Rider University
| 4 years |
James M. Pollock | M | 50 | 2 years | |
Nelson A. Zamora | M | - |
Rider University
| 4 years |
Gregory Senkevitch | M | - |
Rider University
| 4 years |
Nicholas Ventura | M | - |
Rider University
| 4 years |
Anthony Pascucci | M | - |
Rider University
| 4 years |
Louis Desiderio | M | - |
Rider University
| 4 years |
Linda Brooks | F | - |
Rider University
| 4 years |
Anant Agrawal | M | - | 3 years | |
Andrew Forte | M | 65 |
Rider University
| 4 years |
Robert J. Manzo | M | 66 |
Rider University
| 4 years |
John Cooper | M | 65 |
Rider University
| 4 years |
Patrick McGuiness | M | 58 |
Rider University
| 4 years |
William L. van Alen | M | 89 | 17 years | |
Karen Dykstra | F | 65 |
Rider University
| 4 years |
David Harris | M | 64 |
Rider University
| 4 years |
Sascha P. Fedyszyn | M | 49 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 12 years |
Bruce C. Galton | M | 72 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | 8 years |
Roger Dale Ward | M | 71 |
Rider University
| 4 years |
James E. Bartolomei | M | 63 |
Rider University
| 4 years |
Albert Passner | M | - | 1 years | |
Peter A. Michel | M | 81 | 1 years | |
James Joseph Graziano | M | 56 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
Miguel A. de los Ríos | M | 49 |
Sevion Therapeutics, Inc.
Sevion Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sevion Therapeutics, Inc. operates as Biopharmaceutical Company. It discovers, develops and acquires product candidates for the treatment of cancer and immunological diseases. The company was founded on September 30, 1999 and is headquartered in San Diego, CA. | - |
James D. Smith | M | 65 | 1 years | |
Christopher Glenn King | M | - |
Rider University
| 5 years |
Glenn Scott Dorsey | M | - |
Rider University
| 4 years |
John McLaughlin | M | - | 5 years | |
Clare M. Carmichael | F | 64 |
Rider University
| 4 years |
John Thomas Donohue | M | - |
Rider University
| 4 years |
Mandeep S. Arora | M | - | 1 years | |
Stephen W. McHugh | M | 66 | 3 years | |
Bruce R. Shirey | M | - | - | |
Veronica Rosa | F | - | - | |
Michael Wasserfuhr | M | 58 | - | |
Stephen E. Gerard | M | - |
Rider University
| 4 years |
Ross Smith | M | - |
Rider University
| 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 85 | 96.59% |
United Kingdom | 3 | 3.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Joel P. Brooks
- Personal Network